Sensitivity and specificity of epstein-barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review
- 3 June 2004
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 26 (7) , 598-602
- https://doi.org/10.1002/hed.20022
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Serologic Markers of Epstein–Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese MenNew England Journal of Medicine, 2001
- Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year periodOral Oncology, 1998
- Serological mass survey for early detection of nasopharyngeal carcinoma in wuzhou city, chinaInternational Journal of Cancer, 1982
- Nasopharyngeal carcinoma: Significance of changes in epstein‐barr virus‐related antibody patterns following therapyInternational Journal of Cancer, 1977
- Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinomaBritish Journal of Cancer, 1976
- Demonstration of epstein‐barr virus‐associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsiesInternational Journal of Cancer, 1974
- PRECIPITATING ANTIBODY IN HUMAN SERUM TO AN ANTIGEN PRESENT IN CULTURED BURKITT'S LYMPHOMA CELLSProceedings of the National Academy of Sciences, 1966